The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy and ...

Researchers have demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides, another class of drugs, to override the incorrect stop signal in some genetic diseases.

An international team of researchers, including scientists of the University of Groningen, have now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides ...

Conclusion. Determining appropriate aminoglycoside dosage in patients with SCI is challenging because such patients exhibit physiological changes that lead to their having different aminoglycoside ...

An international team of researchers, including scientists of the University of Groningen, have now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides ...

Of note, no trials have assessed clinical outcomes; therefore, it is unclear whether the application of these pharmacokinetic differences in aminoglycosides to dosing in patients with SCI ...